786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits

por Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Ansari, Wajeeha, Simón Campos, Jesus Abraham, Pypstra, Rienk, Rusnak, James M
Publicado 2022

Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial

por Hobbs, F. D. Richard, Montgomery, Hugh, Padilla, Francisco, Simón-Campos, Jesus Abraham, Kim, Kenneth, Arbetter, Douglas, Padilla, Kelly W., Reddy, Venkatesh Pilla, Seegobin, Seth, Streicher, Katie, Templeton, Alison, Viani, Rolando M., Johnsson, Eva, Koh, Gavin C. K. W., Esser, Mark T.
Publicado 2023

Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial

por Bian, Huijie, Chen, Liang, Zheng, Zhao-Hui, Sun, Xiu-Xuan, Geng, Jie-Jie, Chen, Ruo, Wang, Ke, Yang, Xu, Chen, Shi-Rui, Chen, Si-Yu, Xie, Rong-Hua, Zhang, Kui, Miao, Jin-Lin, Jia, Jun-Feng, Tang, Hao, Liu, Shuang-Shuang, Shi, Hong-Wei, Yang, Yong, Chen, Xiao-Chun, Malhotra, Vinay, Nasir, Nosheen, Khanum, Iffat, Mahmood, Faisal, Hamid, Saeed, Stadnik, Claudio Marcel Berdun, Itinose, Kengi, de Oliveira, Caroline Cândida Carvalho, Dusilek, Cesar, Rivabem, Lucas, Cavalcante, Adilson Joaquim Westheimer, Lopes, Suzara Souto, Saporito, Wladmir Faustino, Fucci, Fábio José Concilio, Simon-Campos, Jesus Abraham, Wang, Ling, Liu, Lin-Na, Wang, Qing-Yi, Wei, Ding, Zhang, Zheng, Chen, Zhi-Nan, Zhu, Ping
Publicado 2023